ORBIMED ADVISORS LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$5.0B
Holdings
110
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (110 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —YS BIOPHARMA CO LTD | 3,236,311 | $1.7B | 33.03% | |
| 102 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $1.5B | 30.30% | |
| 103 | PHGEBIOMX INC | 4,517,589 | $1.3B | 25.26% | |
| 104 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,241,274 | $1.1B | 22.83% | |
| 105 | GONGERON CORP | 485,000 | $1.0B | 20.44% | |
| 106 | VIRVIR BIOTECHNOLOGY INC | 101,000 | $1.0B | 20.29% | |
| 107 | AGIOAGIOS PHARMACEUTICALS INC | 45,000 | $1.0B | 20.01% | |
| 108 | CALCCALCIMEDICA INC | 297,380 | $850.5M | 16.99% | |
| 109 | —ELEVATION ONCOLOGY INC | 1,500,000 | $805.5M | 16.09% | |
| 110 | AFIBACUTUS MED INC | 2,648,386 | $534.7M | 10.68% | |
| 111 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $248.8M | 4.97% |
PreviousPage 2 of 2